A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective

Authors:

Brereton N, Bodger K, Kamm MA, Hodgkins P, Yan S and Akehurst R.

Publication Type:

Journal Article

Publication Name:

Journal of Medical Economics

Citation:

Brereton N, Bodger K, Kamm MA, Hodgkins P, Yan S and Akehurst R. A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective. J Med Econ. 2010;13(1):148-61.


Link to publication ⟶

⟵ Back to Search Results